PMID- 11003834 OWN - NLM STAT- MEDLINE DCOM- 20001120 LR - 20220215 IS - 0950-1991 (Print) IS - 0950-1991 (Linking) VI - 127 IP - 20 DP - 2000 Oct TI - Positive and negative interactions of GDNF, NTN and ART in developing sensory neuron subpopulations, and their collaboration with neurotrophins. PG - 4335-44 AB - Glial cell line-derived neurotrophic factor (GDNF), neurturin (NTN) and neublastin/artemin (ART) are distant members of the transforming growth factor beta family, and have been shown to elicit neurotrophic effects upon several classes of peripheral and central neurons. Limited information from in vitro and expression studies has also substantiated a role for GDNF family ligands in mammalian somatosensory neuron development. Here, we show that although dorsal root ganglion (DRG) sensory neurons express GDNF family receptors embryonically, they do not survive in response to their ligands. The regulation of survival emerges postnatally for all GDNF family ligands. GDNF and NTN support distinct subpopulations that can be separated with respect to their expression of GDNF family receptors, whereas ART supports neurons in populations that are also responsive to GDNF or NTN. Sensory neurons that coexpress GDNF family receptors are medium sized, whereas small-caliber nociceptive cells preferentially express a single receptor. In contrast to brain-derived neurotrophic factor (BDNF)-dependent neurons, embryonic nerve growth factor (NGF)-dependent nociceptive neurons switch dependency to GDNF, NTN and ART postnatally. Neurons that survive in the presence of neurotrophin 3 (NT3) or neurotrophin 4 (NT4), including proprioceptive afferents, Merkel end organs and D-hair afferents, are also supported by GDNF family ligands neonatally, although at postnatal stages they lose their dependency on GDNF and NTN. At late postnatal stages, ART prevents survival elicited by GDNF and NTN. These data provide new insights on the roles of GDNF family ligands in sensory neuron development. FAU - Baudet, C AU - Baudet C AD - Laboratory of Molecular Neurobiology, Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 77 Stockholm, Sweden. FAU - Mikaels, A AU - Mikaels A FAU - Westphal, H AU - Westphal H FAU - Johansen, J AU - Johansen J FAU - Johansen, T E AU - Johansen TE FAU - Ernfors, P AU - Ernfors P LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Development JT - Development (Cambridge, England) JID - 8701744 RN - 0 (Artn protein, mouse) RN - 0 (Drosophila Proteins) RN - 0 (Gdnf protein, mouse) RN - 0 (Glial Cell Line-Derived Neurotrophic Factor) RN - 0 (Glial Cell Line-Derived Neurotrophic Factor Receptors) RN - 0 (Ligands) RN - 0 (Nerve Growth Factors) RN - 0 (Nerve Tissue Proteins) RN - 0 (Neurotrophin 3) RN - 0 (Neurturin) RN - 0 (Nrtn protein, mouse) RN - 0 (Proto-Oncogene Proteins) RN - EC 2.7.10.1 (Proto-Oncogene Proteins c-ret) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) RN - EC 2.7.10.1 (Ret protein, Drosophila) RN - P658DCA9XD (neurotrophin 4) SB - IM MH - Animals MH - Cell Survival MH - *Drosophila Proteins MH - Ganglia, Spinal/*embryology MH - Glial Cell Line-Derived Neurotrophic Factor MH - Glial Cell Line-Derived Neurotrophic Factor Receptors MH - Ligands MH - Mice MH - Mice, Inbred C57BL MH - Mice, Mutant Strains MH - Nerve Growth Factors/genetics/*metabolism MH - Nerve Tissue Proteins/genetics/*metabolism MH - Neurons, Afferent/*cytology MH - Neurotrophin 3/metabolism MH - Neurturin MH - Proto-Oncogene Proteins/metabolism MH - Proto-Oncogene Proteins c-ret MH - Receptor Protein-Tyrosine Kinases/metabolism EDAT- 2000/09/27 11:00 MHDA- 2001/02/28 10:01 CRDT- 2000/09/27 11:00 PHST- 2000/09/27 11:00 [pubmed] PHST- 2001/02/28 10:01 [medline] PHST- 2000/09/27 11:00 [entrez] AID - 10.1242/dev.127.20.4335 [doi] PST - ppublish SO - Development. 2000 Oct;127(20):4335-44. doi: 10.1242/dev.127.20.4335.